Dingdang Health repurchases 94,500 shares on 4 June; cumulative buy-backs hit 71.59 million under 2025 mandate

Bulletin Express06-04

Dingdang Health Technology Group Ltd. disclosed that it bought back 94,500 ordinary shares on 4 June 2026 through on-market transactions at HK$0.84–0.85 per share, spending HK$0.08 million in aggregate.

Including this latest tranche, the company has repurchased 71.59 million shares since the current mandate was approved on 28 May 2025, utilising 5.43 % of the 1.32 billion shares then in issue. The board is authorised to repurchase up to 131.95 million shares under the mandate.

Repurchases conducted between 19 May and 4 June 2026 total 6.77 million shares—about 0.54 % of the existing 1.25 billion issued shares—and are pending formal cancellation.

Following the 4 June transaction, Dingdang Health’s issued share capital remains unchanged at 1.25 billion shares; the company holds no treasury shares. In accordance with Main Board Rule 10.06(3)(a), the issuer is restricted from announcing or carrying out any new equity issuance until 4 July 2026.

All repurchases were executed in compliance with Hong Kong Stock Exchange regulations and the explanatory statement dated 30 April 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1135384395?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135384395","market":"us","top_or_hot":-1,"title":"Dingdang Health repurchases 94,500 shares on 4 June; cumulative buy-backs hit 71.59 million under 2025 mandate","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. disclosed that it bought back 94,500 ordinary shares on 4 June 2026 through on-market transactions at HK$0.84–0.85 per share, spending HK$0.08 million in aggregate.</p>\n<p>Including this latest tranche, the company has repurchased 71.59 million shares since the current mandate was approved on 28 May 2025, utilising 5.43 % of the 1.32 billion shares then in issue. The board is authorised to repurchase up to 131.95 million shares under the mandate.</p>\n<p>Repurchases conducted between 19 May and 4 June 2026 total 6.77 million shares—about 0.54 % of the existing 1.25 billion issued shares—and are pending formal cancellation.</p>\n<p>Following the 4 June transaction, Dingdang Health’s issued share capital remains unchanged at 1.25 billion shares; the company holds no treasury shares. In accordance with Main Board Rule 10.06(3)(a), the issuer is restricted from announcing or carrying out any new equity issuance until 4 July 2026.</p>\n<p>All repurchases were executed in compliance with Hong Kong Stock Exchange regulations and the explanatory statement dated 30 April 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health repurchases 94,500 shares on 4 June; cumulative buy-backs hit 71.59 million under 2025 mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health repurchases 94,500 shares on 4 June; cumulative buy-backs hit 71.59 million under 2025 mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-04 18:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. disclosed that it bought back 94,500 ordinary shares on 4 June 2026 through on-market transactions at HK$0.84–0.85 per share, spending HK$0.08 million in aggregate.</p>\n<p>Including this latest tranche, the company has repurchased 71.59 million shares since the current mandate was approved on 28 May 2025, utilising 5.43 % of the 1.32 billion shares then in issue. The board is authorised to repurchase up to 131.95 million shares under the mandate.</p>\n<p>Repurchases conducted between 19 May and 4 June 2026 total 6.77 million shares—about 0.54 % of the existing 1.25 billion issued shares—and are pending formal cancellation.</p>\n<p>Following the 4 June transaction, Dingdang Health’s issued share capital remains unchanged at 1.25 billion shares; the company holds no treasury shares. In accordance with Main Board Rule 10.06(3)(a), the issuer is restricted from announcing or carrying out any new equity issuance until 4 July 2026.</p>\n<p>All repurchases were executed in compliance with Hong Kong Stock Exchange regulations and the explanatory statement dated 30 April 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1135384395","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135384395","pubTimestamp":1780569795,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. disclosed that it bought back 94,500 ordinary shares on 4 June 2026 through on-market transactions at HK$0.84–0.85 per share, spending HK$0.08 million in...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康6月4日回购9.45万股；2025年授权下累计回购达7159万笔","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. disclosed that it bought back 94,500 ordinary shares on 4 June 2026 through on-market transactions at HK$0.84–0.85 per share, spending HK$0.08 million in aggregate.\nIncluding this latest tranche, the company has repurchased 71.59 million shares since the current mandate was approved on 28 May 2025, utilising 5.43 % of the 1.32 billion shares then in issue. The board is authorised to repurchase up to 131.95 million shares under the mandate.\nRepurchases conducted between 19 May and 4 June 2026 total 6.77 million shares—about 0.54 % of the existing 1.25 billion issued shares—and are pending formal cancellation.\nFollowing the 4 June transaction, Dingdang Health’s issued share capital remains unchanged at 1.25 billion shares; the company holds no treasury shares. In accordance with Main Board Rule 10.06(3)(a), the issuer is restricted from announcing or carrying out any new equity issuance until 4 July 2026.\nAll repurchases were executed in compliance with Hong Kong Stock Exchange regulations and the explanatory statement dated 30 April 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1135384395","isCrawlerRequest":true}